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Abstract

THE EFFECTS OF CYCLIC STRAIN ON RAT TAIL TENOCYTES
Richard Crockett, Michael Centrella, Thomas McCarthy, J. Grant Thomson. Section of
Plastic Surgery, Department of Surgery, Yale University, School of Medicine, New
Haven, CT.

The purpose of this study was to examine the effects of cyclic tension on the
expression of hyaluronic acid, its receptor (CD44), and total glycosaminoglycan content
in tendon fibroblasts. An in vitro model was used to analyze tenocytes from the tail
tendons of rats. Tenocytes in the experimental group were exposed to cyclic mechanical
stress, and using ELISA, western blot, and colormetric dye-binding assays, the effect of
strain on cultured tenocytes was examined.
Tenocytes exposed to mechanical strain produced 1528 ± 58 ng/mL (mean ±
SEM) of hyaluronic acid, while those in a control environment produced only 730 ± 27
ng/mL; nearly a two-fold difference (p<.0001, n=44). CD44, the receptor for hyaluronic
acid, was also detected in higher concentrations. Tenocytes under mechanical strain
increased their concentration of CD44 by 62.5%, with tenocytes exposed to strain having
an optical density of 26 · 103 ± 2 · 103 compared with 15 · 103 ± 1 · 103 in controls (p<.05,
n=6). The total glycosaminoglycan content of the two groups did not differ significantly;
strained cells produced 10.2 ± 0.6 µg/mL and controls producing 15.3 ± 3 µg/mL
(p=0.103, n=44).

We conclude that mechanical strain in tendon fibroblasts is sufficient to induce
the production of hyaluronic acid and increase the expression of its receptor, CD44. The
results of our study suggest that the beneficial effects on tendon adhesion formation seen
with both mechanical strain and hyaluronic acid may be related in their mechanism.
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Introduction

No subject has created more challenges, interest, or discussion in the field of hand
surgery than flexor tendon injuries. Controversies on the proper approach to tendon
surgery began as early as Galen and Avicenna, and by the 1930s, Bunnell had coined the
term “No Man’s Land” to describe a portion of the hand in which tendon injuries caused
particular tribulation.(1)
The great difficulty with repairing flexor tendons surgically is the frequent
creation of fibrotic adhesions between the tendon and surrounding tissues. These
accumulations of scar tissue prevent the smooth gliding of the tendons, limiting
movement and causing debilitating contractures that are the bane of hand surgeons.
The challenge presented by adhesions has been the focus of many research
endeavors. Unfortunately, to date these have met with limited success. Are they truly a
“biologic inevitability” as some authors(2) have described them?

Adhesions have long been an obstacle to proper healing after tendon injury or
repair(3) and have many causes.(4) They differ in their degree of density, and different
types of adhesions may be caused by independent regulatory pathways. This has led to
attempts by some researchers to develop a standard methodology of measuring adhesion
biomechanical strength.(5) Dense adhesions, for example, are characterized not only by
an increased quantity of collagen than loose adhesions, but also with an increase in the
ratio of type III to type I collagen and their ratio of cross-linking.(6) In tendons,
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fibroblasts from the fibro-osseous sheath have biochemical and cellular differences which
may enable them to migrate and contribute to their role in adhesion formation.(7)
Many techniques have been developed to mitigate the development of adhesions
in tendons including: enveloping the repaired tendons within silicone sheathes(8), fibrin
glues(9, 10), iontophoresis(11), pulsed electromagnetic fields(12, 13), and thermal
preconditioning to induce the formation of cytoprotective heat shock proteins(14, 15).
The results have not translated into successful clinical applications.
A number of biochemical agents have also been used to thwart the formation of
adhesions. Non-steroidal anti-inflammatory agents that inhibit cyclooxygenase (COX)
and in turn, prostaglandin synthesis, have received some attention. Indomethacin has
been shown to be beneficial at reducing adhesions(16-19), and some work shows that
ibuprofen can also reduce adhesions in both oral(20) and injectable(21) form.
Conversely, prostaglandins are known to cause or facilitate adhesion formation.(22)
Corticosteroids(23, 24) and promethazine(25, 26) have also been seen to exert a favorable
effect. Some of the benefits to pharmacological anti-inflammatory therapy may be due to
the decreased edema in tissues. This is supported by biomechanical animal studies which
examine the time course of gliding function after injury and reveal a significant
impediment to gliding within hours of injury, long before adhesion formation can
occur.(27)
Intraoperative exposure of repaired tendons to 5-fluorouracil has been shown to
diminish adhesion formation in rabbit(28, 29) and chicken(30) models, as well as
reducing the level of TGFβ1 (thought to be involved in the formation of adhesions).(29)
Later research has shown that this does not decrease the strength of the tendon repair.(31)
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This may be due to its inhibitory effects on matrix metalloproteinases (particularly mmp2
and 9).(32) Aprotinin, another protease inhibitor, has similarly been shown to be
effective in reducing adhesion formation(33) as has halofuginone, an inhibitor of collagen
I transcription(34) and Beta-aminopropionitrile (BAPN), an inhibitor of collagen
maturation.(35) The effect of these chemicals is to hinder collagen production, a needed
component for the creation of adhesions. Collagen itself, when added topically to injured
tendons, induces the upregulation of collagenase to mediate these effects.(36-38)
Although some of these have shown promise, the data are usually limited to small
case series or animal models with clinical trials often yielding disappointing results.
Despite some indications to the contrary(39, 40), physical barriers to adhesion formation
such as PTFE have also not proven a useful technique(41-45). The use of an antiadhesive membrane (ADCON-T/N) was evaluated in human flexor tendon repair in a
prospective double-blind randomized control trial (RCT), and total active motion was
evaluated at 3, 6, and 12 months after the repair. Although the length of time taken to
achieve the final range of motion was shorter in treated patients, the total range of motion
achieved was not improved.(46) The failure of ADCON-T/N to prevent adhesions has
been supported by other researchers.(47)
As a whole, these studies emphasize that there are a variety of factors which may
influence the formation of adhesions after tendon surgery. Along with these biochemical
signals, mechanical strain also seems to be important for the proper functioning and
healing of tendons. The tension-bearing property of tendons is important for the normal
mechanics of joint motion. Unfortunately, after surgery tendon motion is limited by pain
and rupture rates can be high if motion is allowed. Depending on the particular repair
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technique and mobilization protocol, the rupture rates of digital flexor tendons range
from 4%(48) to 46%(49) and 17% for thumbs(50). On average, the rupture rate
approaches 10%(48, 50-65), and the rate of “excellent” or “good” results (using
Strickland’s revised scoring technique, a commonly used tool to evaluate outcomes of
hand surgery(53)) is often below 75%, although individual results vary considerably.
Historically, hand immobilization was used to protect flexor tendons after repair.
This period often lasted three or more weeks, and while effective at minimizing the risk
of tendon rupture, it had the disadvantage of maximizing the formation of adhesions.
More recently, a substantial body of literature describing the beneficial role of early hand
mobilization has been published. We now know that mobilization is beneficial to the
smooth gliding of tendons and prevention of adhesions. And although active
mobilization can result in rupture(66) or gap formation(67) in animal models, most data
suggest a positive role. Overall, animal models using active rehabilitation mobilization
protocols have been shown to decrease adhesion formation without undue risk of rupture
when compared to immobilization.(68) This translates into repairs which are stronger,
have a more efficient healing process(69) and greater range of motion(70) in the joints
that they affect.
The timing of when tendon mobilization is started after surgery is also an
important factor. In a study that examined canine flexor tendons after surgical repair,
immediate mobilization was superior to delayed mobilization in returning range of
motion (a 50% increase) and dramatically better than immobilized tendons (more than a
five-fold improvement in angular rotation).(71) This benefit has been corroborated by
other studies.(72)
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There is still some discussion on which protocols maximize the beneficial effects
of mechanical strain while introducing the least risk of rupture. It is known that several
parameters play a role in determining outcome. The frequency of motion, for example, is
an important factor, with increased frequency correlated with improved tensile
strength.(73) A prospective multi-center RCT was performed to examine the effects of
daily passive motion and whether increased duration of motion could improve tendon
gliding after flexor tendon repair. The authors report that there was a significant benefit
to increased duration of controlled motion on the range of motion, increasing the angle of
rotation by 19 degrees.(74)
This has also translated into clinical research(74-76), and it is now clinically
accepted practice to apply these protocols to patient care as the most effective method of
preventing adhesions(4) even in the presence of concurrent digital nerve injuries.(77)
Previously, it was thought that active mobilization protocols (involving the
contraction of muscles in continuity with the repaired tendons) would lead to
unacceptable rupture rates. Mobilization however, both active and passive, helps tendon
healing and decreases adhesion formation. Animal studies have supported a benefit to
tendon strength and smooth gliding by using controlled passive movement(78) as well as
active movement. Prospective trials in humans have shown an advantage in patients who
have passive(79) and active(57-59) post-operative mobilization. Although some authors
report an advantage to active motion(62), at least some data suggest that neither is
superior to the other.(49) Active motion can result in higher rupture rates, but an analysis
of different protocols shows that the risk can be comparable to passive motion if
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performed judiciously(63) and if the patient avoids imprudent acts which account for half
of all tendon ruptures.(50)
Cyclic mechanical loading of tendons to mimic strains encountered during
mobilization protocols reveals that tenorraphy failure rates may depend on the repair
technique used.(80) Indeed, there is an entire body of literature which examines the
surgical techniques of tendon repair(42) which will not be discussed at length here except
to say that after tendon injury or repair, there is an increase in the friction of tendon
gliding which remodels with time.(81) High friction suture techniques(82) and many
other factors(83) may centrally contribute to adhesion formation and possibly rupture.

Fibroblasts show a response to mechanical strain in vitro at both a cellular and
biochemical level.(84) Tendons in vivo exposed to extracorporeal shock waves after
injury have been shown to have an increased number of capillaries and decreased
formation of adhesions, with a correspondingly higher force required to cause
rupture.(85)
Cyclical mechanical strain, in particular, seems to be important. When exposed to
cyclic mechanical strain, flexor tendons fibroblasts proliferate and align in the direction
of tension to form a thicker growth layer.(86) Constant strain, however, appears to be of
lesser benefit in healing tendons.(87, 88)
One question that exists regarding the effect of mechanical strain on healing
tendons is the degree to which strain actually contributes to the improvements seen with
active and passive motion rehabilitation protocols. One theory might argue that only
motion is important, as the primary mechanism is the mechanical separation of fibrotic
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bridges which are putative adhesions. Another view is that the strain is primarily
important, as the host of growth factors regulated by and affecting strain certainly plays a
role.
The question was addressed by a study which examined in vivo chicken flexor
tendons. Motion and strain each had an independent roll in generating tensile strength,
and the combination of the two was greater than either alone. An increase in collagen
production, however, was seen only when tendons experienced some type of strain.(89)
Other studies have shown that the degree of excursion (change in joint angle) is of
minimal importance in determining the extent of adhesion formation or whether a repair
will have good range of motion.(90)
The effect of mechanical strain on the growth factor milieu of tendons is
paramount. After tendon injury or repair, a host of growth factors are upregulated.
Microarray analysis of rat flexor tendons under strain demonstrate an “antifibrotic”
pattern of gene regulation, with decreased transcription of collagen I and III, FGF, PDGF,
and IGF1.(91) IGF has been shown to promote fibroblast growth in culture.(92-94) In
contrast, TGFβ1 (which is often associated with increased adhesion formation) was found
to be upregulated during strain in this study.(91) The import of this is somewhat unclear.
The regulation of the TGFβ pathway seems to be particularly important in the
pathogenesis of fibrosis and formation of adhesions. It has been shown to be associated
with adhesion formation, and some studies show that the addition of TGFβ to tenocytes
in vitro can increase collagen production(95), while neutralizing antibodies to TGFβ can
decrease collagen production(96). The role of individual isoforms of TGFβ (TGFB1, 2,
and 3) are not yet clear. Most evidence points to TGFβ1 acting to contribute to adhesion
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formation, and less so for TGFβ2 and 3. This has been supported by research showing
decreased adhesion formation in the presence of TGFβ1 blocking antibodies(97) and the
observation that although TGFβ1 is expressed in healthy tenocytes, the levels rise sharply
after tendon injury.(98)
Some research suggests that the site of action of individual growth factors varies
significantly. In one study which examined the effect of a tendon injury on growth factor
regulation at ten days after injury, TGFβ was detected around the repair site and just
proximal to it, while other factors such as VEGF and PDGF were expressed throughout
the tendon. Some growth factors such as EGF, IGF, and bFGF were not seen in
tenocytes; only in pro-inflammatory cells in the repair site.(99) This increase in TGFβ
activation is most pronounced in the tendon sheath and epitenon, peaking within two
weeks of injury or repair.(100)
The expression of VEGF in injured tendons suggests that the supply of nutrients
and oxygen may be an important factor in determining the adhesion forming response of
healing tendons. When tendons are examined after repair, progressive changes in the
microvasculature can be observed.(101) Revascularization of tendons following injury
occurs progressively over a 7-21 day window, forming an extrinsic vascular supply.(102)
In one study, the authors noted a decreasing density and more longitudinal orientation of
vessels associated with an increasing range of motion after the acute healing phase of the
first 21 days had passed.(103)
Other vascular signaling intermediaries have been implicated as well. Nitric
oxide synthase (NOS) levels double after an acute tendon injury, and appear to be
integral to the repair process. Blocking NOS production creates a persistent, chronic
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inflammatory response that leads to an increased incidence and severity of
adhesions.(104) Lactate can also modulate early wound healing and can stimulate
collagen production after injury. Cultured tendon cells exposed to lactate have been
shown to increase collagen production(105), suggesting that lactate levels may directly
modulate collagen production during tendon wound healing or repair.
As newer molecular biology techniques become available, they will advance our
understanding of the complex growth factor regulation that plays a critical role in the
biology of adhesion formation and tendon healing. Adenovirus mediated gene transfer
appears to be an efficient, dose dependent method of delivering transgenes to flexor
tendons and at viral concentrations of less than 109, does not appear to engender a
significant inflammatory response.(106) Also, antisense oligonucleotides to procollagen
have been shown effective at reducing collagen production in human tenocytes.(107)
In sum, many applications for the prevention of adhesions after tendon repair
have been tried. Unfortunately, few have met with clinical success. To understand the
biological basis of adhesions, a closer look at tendon biology is warranted.

Tendon is specialized connective tissue specifically designed to withstand tension
and allow the smooth gliding of tissues. On gross examination, tendons themselves are
bright white cord or band-like structures that form the structural connections between
bone and muscle. Water constitutes approximately 70% of tendon mass(108) with
collagen I accounting for the majority of the dry mass. Tendons contain additional
structural elements, including bone attachment and insertion sites, blood vessels, and a
dense extracellular matrix. The primary role of tendons is structural, which is reflected in
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their decreased metabolic activity. Oxygen consumption, for example, is 7.5 fold lower
when compared with skeletal muscles.(109) This property allows them to function in
relatively ischemic environments; an important adaptation as tendons are commonly in
compact anatomical regions with limited tissue perfusion and often under enormous
tension which would otherwise cause tissue necrosis. However, the decreased metabolic
rates also contribute to slower healing after a traumatic insult.(110)
Although tendons contain some elastin, they are comprised predominantly of
thick collagen type I fibers and spindle-shaped tenocytes interspersed in a columnar
fashion among the fibers. The glycosaminoglycan hyaluronic acid (hyaluronan,
hyaluronate) is present in small quantities. External to the collagen fibers is a layer of
paratenon fibroblasts. The internal fibroblast may be responsible for the bulk of the
collagen synthesis, whereas the external cells may provide lubrication for tendon gliding
during motion.(111)
At a micro-structural level, tendons are formed by the successive grouping of
larger and larger bundles of fibers. At the smallest level, a triple-helix polypeptide chain
forms “primary bundles” of tropocollagen which are only 15 angstroms in diameter.
Several small fibers of tropocollagen together form a 35 angstrom microfibril, many of
which unite to form a subfibril of 100-200 angstroms in width. Subfibril groups form
500-5000 angstrom fibrils, and eventually the 50-300 µm fascicles of tendons.(112)
Each bundle of tendon collagen is covered by an endotenon. The septa of these
endotenon form together to constitute an external epitenon that covers the threedimensional surface of the tendon. This is further complemented in the hand by a thin
adventitia known as the paratenon within a synovial-like fluid environment.(42)
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This arrangement is coupled by a complex waveform or crimp structure of
different topographies that forms a dynamic rope-like tendon capable of tremendous
tensile strength. Biomechanical analyses, for example, reveal that tendons can withstand
forces equivalent to thousands of Newtons.(113) The capacity to produce such a robust,
complex structure lies in the equally intricate arrangement of cellular subtypes.
Tendons contain several types of cells. Tenocytes (or tendon fibroblasts) account
for 90 to 95% of tendon cells. Synovial cells, chondrocytes located near osseous
insertions sites, endothelial cells, smooth muscle cells of arterioles, and immunologic
cells form the remainder. Collectively, they are responsible for the formation,
maintenance and interactions of the extracellular matrix.
Along with the previously mentioned cellular components, extracellular fluid, and
collagen and elastin fibers, the extracellular matrix (ECM) contains a fourth component –
the ground substance. Ground substance is the portion of the extracellular matrix
comprised of glycoproteins and proteoglycans – large molecules which are formed by the
union of a glycosaminoglycan through a trisaccharide link to a protein core.
Glycosaminoglycans (or GAGs) are synonymous with “mucopolysaccharides” and exist
independently in the extracellular matrix as the most plentiful heteropolysaccharides in
the body. GAGs are formed as long polymers of modified disaccharides and uronic acid.
Because of their large size (molecular weights in the tens of millions) and predilection for
absorbing water, glycosaminoglycans often play a structural role in lubrication or
minimizing mechanical compression.
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One glycosaminoglycan of particular interest is hyaluronic acid (HA).
Hyaluronic acid is a high molecular weight glycosaminoglycan first described in
1934.(114) It is formed by the repeating disaccharide N-acetylglucosamine and Dglucuronate.(115) Because of its high molecular weight, random coiled structure, and
ability to attract water, hyaluronic acid is hydrodynamic and forms solutions that have
high viscosity, elasticity, and propensity for filtration.(114)
Hyaluronic acid is unique in that it is not sulfated and not covalently bonded to a
protein, though it does complex with other proteoglycans. It lubricates tendon tissues and
is thought to play an important role in the early stages of connective tissue healing and
scarless fetal wound healing.(116-119) In an experimental model involving fetal lambs,
tendons which were injured healed with no subcutaneous scaring, no adhesions, and
regained a smooth gliding surface with well organized collagen architecture, although
adult sheep controls experienced significant dense scarring and adhesions.(120)
Interestingly, it has been shown that acellular amnion membrane (which contains
elevated concentrations of hyaluronic acid(121)) can prevent the adhesion of tendons
after repair without compromising tendon healing.(122, 123) In one study, the combined
effect of amniotic membranes applied in conjunction with hyaluronic acid was examined.
Although the researchers reported that this was greater than either amniotic membrane or
hyaluronic acid alone, it did not reach statistical significance.(124) Other studies,
however, have shown in animal models that topical amniotic fluid alone applied during
tendon repair is sufficient to both decrease adhesion formation and improve the tensile
strength of the repair.(125)
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In animal models of osteoarthritis, the addition of hyaluronic acid has been shown
to provide a lubricating effect, decreasing the friction of tissues.(126) Even in healthy
joints, the lubricating effect of hyaluronic acid can be seen.(127)
It has been suggested that the molecular weight of hyaluronic acid plays an
important role in determining its effect on adhesion formation.(128) Some investigators
have attempted to examine whether the molecular weight affects the mechanical friction
in joints. In one study, the researchers injected 1% hyaluronic acid of two different
molecular weights into the joint spaces of rabbits and determined that molecular weight
did not play a role in determining the lubricating characteristics.(129) Unfortunately, the
molecular weights chosen by the researchers were both similar (one and two million
Daltons) and relatively low. As a consequence, they may not have been sufficiently
different to allow for detection of lubricating or signaling potential. Moreover, it may not
be the lubricating role of hyaluronic acid that is central to its effects on tendon healing.
Hyaluronic acid was previously thought to be an inert molecule that provided
mechanical compression support in connective tissues. It is now understood that
hyaluronan is an active ligand that exerts important regulatory and healing effects
through hyaluronan-binding proteins, also known as hyaladherins.(114) These
interactions make hyaluronic acid an important player in regulating cell mobility,
adhesion, and proliferation; all important cellular functions in tendons. Hyaluronic acid
is also present intracellularly and may be incorporated from extracellular stores(130), or
produced de novo from within the cell(131) where it is thought to influence cell
proliferation and motility.(114)
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CD44, the primary receptor for hyaluronic acid(132), was first cloned in
1989.(133) Antibody mediated activation of the CD44 receptor produces an antiinflammatory response(134) and organisms which are engineered to eliminate CD44 gene
expression (-/-) are unable to properly respond to injury.(114) In addition, hyaluronic
acid and its primary receptor, CD44, have been implicated as important cell adhesion
mediators in the pathogenesis of cancer(135).
Of the many roles hyaluronic acid is thought to have, the most germane to
tendons is its role as a structural lubricant and metabolite in the regulation of cell
proliferation and adhesion formation. Applied topically during flexor tendon repair in
animal models, hyaluronic acid has been shown to decrease adhesions at the repair site
and synovial sheath. In a study involving the flexor tendons in dogs, for example,
hyaluronic acid was applied topically to the second and fifth flexor tendons which had
been transected and repaired. After five weeks of immobilization, the tendons exposed to
hyaluronic acid had a significant decrease in both gross and histological adhesions.(136)
This has also been seen in other studies of rabbits.(137)
After flexor tendon repair, canine tendons exposed to a hyaluronic acidcontaining solution showed reduced excursion resistance.(138, 139) By decreasing the
friction and force on the repaired tendon, increased gliding occurs, which decreases
adhesion formation(140) and the likelihood of rupture.
Multiple in vitro and in vivo animal studies have supported a role for hyaluronic
acid at preventing adhesions.(141, 142) Collagen contents (adhesions) in peri-tendon
tissues are decreased, smooth gliding is improved(143), and range of motion is
greater.(144) Hyaluronic acid has been shown to increase expression of VEGF and
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collagen IV when applied to healing tendons after repair, both potential anti-adhesive
mediators.(140)
Although some studies have not shown hyaluronic acid to decrease adhesion
formation(145-147), they are in the minority. During tendon repair in a rabbit model,
Seprafilm, a bioresorbable membrane containing hyaluronic acid and carboxymethyl
cellulose, worked as well as hyaluronic acid gel in the prevention of adhesions and
improvement of range of motion when compared to controls who received no hyaluronic
acid.(148) Benefits are also observed for tenolysis of existing adhesions in a chicken
model(149) and in dogs.(136) Other preparations of hyaluronic acid such as Healon and
viscoelastic gel have been shown to be effective at reducing adhesion formation, even
when injected into zone II flexor tendon repairs in immobilized primates.(150) The
addition of a phospholipid lubricant, dipalmitoyl phosphatidylcholine, has also been
shown to augment the action of hyaluronic acid, decreasing the friction coefficient and
formation of adhesions in rabbit flexor tendons.(151) Exogenously applied hyaluronic
acid has also been shown to inhibit tendon fibroblast proliferation involved in the
formation of adhesions in rabbit models.(152)
A potential role for hyaluronic acid to mitigate adhesion formation is of particular
interest in hand surgery as adhesions can cause significant functional impairment after
surgical tendon repair. Hyaluronic acid, although effective at reducing adhesions
experimentally, has been disappointing clinically.(153, 154)
One of the challenges of applying hyaluronic acid as a therapy is its rapid
absorption in the body. Hyaluronic acid can be degraded within a matter of hours, and
within 24 hours, significant dilution may take place. Higher molecular weight

16
preparations and those that contain a higher initial concentration of hyaluronic acid
experience a slower decline.(155, 156) This is further supported by evidence showing
that hyaluronic acid which has been modified to persist longer has a beneficial effect.
One group of researchers using a chicken model mixed hyaluronate with
carboxymethylcellulose and prevented the formation of dense adhesions.(157)
A rabbit study which reported a beneficial effect from hyaluronic acid, decreasing
adhesion formation from 95% to 45%, also noted that when adhesions did form in the
presence of hyaluronic acid, they were less severe.(158) The authors show in a later
study that improved function may have been a result of increased viscosity of the
hyaluronic acid preparation.(159) Using ex vivo canine tendons as a model, a derivatized
form of hyaluronic acid, which through chemical modification persists longer than native
hyaluronate, maintained a lower gliding resistance over many repeated cycles of tendon
movement than hyaluronic acid or saline.(82)
Clinically, some researchers have reported beneficial results with hyaluronic
acid(160), but the vast majority have not.(42) This disparity between the very promising
in vitro and animal study findings, and the disappointing clinical observations, is an area
of great interest. A better understanding of the biology and regulation of hyaluronic acid
is needed.
It has been shown that removing the tensional loading from tendons either
experimentally or surgically changes matrix characteristics including increases in total
glycosaminoglycan content.(111) Conversely, adding motion to repaired tendons has
been shown to be beneficial to tendon healing, resulting in fewer adhesions, increased
strength of repair, and more longitudinal alignment of collagen bundles compared with
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healing tendons without movement.(54, 71) How tendon cells perceive changes in
tensional loading, however, is not well understood.(161)
While the effects of tensional loading on a variety of protein expression products
in tendon are known(159-168), the effect of mechanical strain on hyaluronic acid
production and its receptor, CD44, is uncharacterized in tendons. Do these two important
mediators of adhesion formation and tendon healing share a common pathway?
There is some evidence that suggest they might. In fibrocartilage tissue,
mechanical strain has been shown to increase hyaluronic acid production and several of
its upstream mediators.(162) If tendon fibroblasts react in a similar way, it would support
the view that the beneficial effects of mechanical strain, the cornerstone of current
clinical management of tendon healing and adhesion prevention, are acting at least in part
through hyaluronic acid, arguably the most promising biochemical player in the
prevention of adhesions. With a better understanding of the biochemistry of hyaluronic
acid and mechanical strain, a more elegant solution to the problem of adhesions may one
day be in hand.

Purpose

The objective of this study was to isolate rat tendon fibroblasts (tenocytes) and to
investigate the effect of cyclical mechanical strain on matrix component production,
specifically hyaluronic acid (HA), its receptor (CD44) and total glycosaminoglycan
(GAG) production.
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Materials and Methods

Note on individual performance of research tasks:
All actual labor for the project including, but not limited to, all procedures, cell
culture work, animal cell and tissue harvesting, all methods and experiments, generation
of data, analysis of data, production of reagents, design and selection of assay systems,
use of assay systems including ELISA, western blots, and colormetric dye-binding
assays, preparation of cell lysates, and antibody utilization were performed personally by
Richard Crockett. In addition, Richard Crockett was personally responsible for the use,
configuration, and repair of the FlexCell unit, as well as the selection, evaluation,
procurement and price negotiation of all required reagents and materials, budget
management, and project timeline planning.

Certain elements of the research relied on personnel other than Richard Crockett:
Training of Richard Crockett in the use of western blot technique and photographic film
use was performed by Dr. Michael Centrella.

Training of Richard Crockett in surgical dissection techniques for rat tail tendons was
performed by Dr. J. Grant Thomson.

Training of Richard Crockett in the culture of tenocytes was performed by Dr. Martijn
van Griensven in Hannover, Germany.
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Certain elements of the conceptual and pragmatic research plan relied heavily on the
creative input of personnel other than Richard Crockett:
Development of laboratory strategies to efficiently obtain data involved discussions with
Dr. Thomas McCarthy and Dr. Michael Centrella.

Development of strategies involved in design of the strain protocol and overall research
goals involved discussions with Dr. J. Grant Thomson.

Methods Summary:
The research involved several stages, which are explained in detail below.
Briefly, rat tail tendons were surgically dissected and the tendon fibroblasts were
removed and cultured. After two passages, these cells were transferred to flexible
membrane culture dishes and assigned to an experimental or control group. The
experimental group was exposed to a cyclical mechanical strain, while the control (or
static) group was not. The cells were then analyzed for changes in three targets of
interest: hyaluronic acid, the receptor for hyaluronic acid (CD44), and total
glycosaminoglycan content.

Harvest of Tendon Cells:
The tendon fascicles were harvested from 12 adult Sprague-Dawley rats (Charles
River Laboratory; Wilmington, MA). All animal care complied with the IACUC and
NIH protocols for the care and use of laboratory animals. The rats were sacrificed with
an overdose of isofluorane and cervical dislocation. The tail and hindquarters were
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immersed in 95% ethanol then thoroughly rinsed in sterile saline. After transecting the
tail, the skin was removed and discarded. The transected tail was transferred to a 150mm
Petri dish (Corning; Corning, NY) and using sterile technique, tendon fascicles from
dorsal, ventral, and lateral tendon groups in the anterior two-thirds of the tail were
removed. After the paratenon was removed, the tissue was divided into 3-5mm2 samples
and placed in 60mm Petri dishes (Corning). For each piece of tissue, a small area of the
dish was abraded with a number 11 scalpel blade. The tissue was allowed to partially air
dry for several minutes in a sterile laminar flow hood in order to increase adherence. 35mL of culture medium was then slowly added. The culture medium consisted of
Dulbecco’s modified Eagle’s Medium (DMEM) with Ham’s F-12 (1:1) and L-glutamine
(Gibco; Grand Island, NY) supplemented with 10% fetal calf serum (Gibco).
Penicillin/streptomycin species (100 U/mL) was also added to the medium.

Culture of Tendon Cells:
In a 37°C non-moving 5% CO2 incubator, the tissue was left undisturbed for 2-3
days. Tenocytes migrated from the clumps of tendon tissue. After tenocyte growth
reached 75-80% confluence, the tendon tissue was removed. The medium was removed
by suction and the dish was bathed in 1-2mL 0.25% trypsin with EDTA (Gibco) at 37°C
for 10 minutes. The trypsonized cells were placed in a 15 mL Falcon tube to which
culture medium was added. The cells were then collected by sedimentation, resuspended
in culture medium and plated in the culture medium on 25cm2 filter-top culture flasks
(Nunc; Roskilde, Denmark). The cells were observed daily under an inverted phasecontrast microscope (Olympus; Melville, NY). Medium was changed every other day.
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When the cells had reached 75-80% confluence, the medium was discarded and
the cells were freed with trypsin as described above. Cells were then split and plated
onto three 80cm2 filter-top culture flasks. When these cells had reached 75-80%
confluence, they were plated on Bioflex® plates (Flexcell International; McKeesport,
PA); culture dishes containing a flexible silastic membrane bottom. These culture dishes
contained 6 wells, with each well bottom consisting of a flexible membrane which had
been previously coated with fibronectin to facilitate fibroblast cell adhesion.
Cultured cells were plated on the same type of Bioflex plate, irrespective of group
(strained or static). Only after the cells had been cultured and were ready for the strain
protocol were the culture dishes assigned in a random fashion to either the strained or
static group. This was done to prevent any selection bias based on cell line. Cell density
was determined using a hemocytometer and cells were plated at approximately 10,000
cells/57.75cm² Bioflex plate.

Strain Protocol:
The Flexercell® Strain Unit applies cyclic strain to cells cultured to confluence on
flexible membranes (Flexcell International). The unit exerts a vacuum pressure on a
silastic membrane at the bottom of each 6-well plate that has been pre-coated with
fibronectin. The unit fits inside a standard CO2 incubator and the duration, frequency,
and magnitude of stress can be adjusted. A 5% change in the size of the membrane
approximates a 2% change in the length of cells on the membranes; similar to the amount
of elongation collagen experiences under physiologic conditions.(161) To select an
appropriate strain regimen, we attempted to mimic active rehabilitation protocols, which
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involve periods of repeated strain followed by comparatively longer periods of rest and
recovery. Previous studies have shown that the magnitude and duration of strain(163), as
well as the length of the rest between stain periods are important parameters(164), but the
frequency of strain is less important.(163) Accordingly, cells were strained at 1 Hz for
five minutes and allowed to rest for 55 minutes. This was repeated over the course of 8
hours, after which the cells were allowed to rest for 24 hours before collection so that any
translational or post-translational events would have sufficient time to occur. Both the
medium and cells were collected for analysis.
Cultured tenocytes were divided into two groups – an experimental group, which
was exposed to the mechanical strain regimen, and a control or static group which was
not exposed to any strain. Both groups were extracted and cultured in identical
conditions at the same time and each replicate was derived from an independent cell
lineage. During the strain regimen, strain cells which had been cultured on the Bioflex 6well plates were placed in the strain unit. Static cells were placed in the same incubator
at the same time as the strained cells but were not exposed to any strain.

Hyaluronic acid content
Hyaluronic acid concentration was measured using an enzyme linked protein
assay (Corgenix; Westminster, CO). Using a capture molecule called Hyaluronic Acid
Binding Protein (HABP) which is bound to horseradish peroxidase (HRP), the assay is
visualized with a chromogenic substrate and measured in optical density with a
spectrophotometer. Because hyaluronic acid is primarily secreted into the extracellular
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tissue matrix, we compared the concentration in the media from strained cells to that
found in the media of static cells.

CD44 receptor expression
Immunolabelling for CD44 was performed using a polyclonal rabbit antibody to
CD44 (Santa Cruz Biotechnology; Santa Cruz, CA). After the medium had been
removed from the Bioflex plates, the cellular layer was collected and homogenized using
a sonicator. The homogenate was normalized for total protein content and separated by
charge to mass ratio using SDS polyacrylamide gel electrophoresis. The proteins were
electroblotted onto PolyScreen polyvinylidene difluoride transfer membrane
(PerkinElmer Life Sciences, Wellesley, MA). The western blot was then probed using
primary antibody (as described above) in TBST with milk at 20°C overnight. The
secondary antibody was goat, anti-rabbit conjugated to HRP (Santa Cruz) and
immunocomplex formation was visualized with chemiluminescence and exposure to
photographic film.

Total glycosaminoglycan (GAG) content
To measure the amount of glycosaminoglycan (GAG) present in the medium, a
colormetric assay was used which involves the binding of a dye (dimethyl-methylene
blue) to GAGs (Biocolor Assays; Newtownabbey, Northern Ireland). A dye solution
which includes DMB dye and an inorganic solvent are added to the sample. The dye is in
excess and binds with GAGs, precipitating out of solution. After centrifugation, the
resulting pellet contains the dye-GAG complex, and the supernatant contains unbound
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DMB dye and solvent. Resuspension of the pellet in propanol to disassociate the dye
from the GAGs allows the concentration of solublized dye to be read on a
spectrophotometer.

Data Analysis
An unpaired two-tailed Student’s t-test was used to compare strained and static
groups. A value of p < 0.05 was considered significant. Western blots were optically
scanned and analyzed using ImageJ (NIH; Bethesda, MD).
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Results

During the harvest of the tendon fibroblasts, 12 animals were dissected and the
tendons were removed. Two additional animals were used solely for practice of the
tissue harvest and culture and were not part of the experiment. Although it was initially
challenging to separate the tendon from the surrounding tissue (including the paratenon),
once the technical elements were refined the process became straightforward. Each
animal yielded a sufficient quantity of tendon tissue such that each control and
experimental cell line consisted of tenocytes with a distinct cell lineage from the others.
These were cultured in parallel, under identical conditions. One culture developed a
fungal infection before assignment to either the experimental or control group and was
discarded.

Hyaluronic Acid Content
Since hyaluronic acid is produced by fibroblasts and found primarily in the
extracellular environment, the medium in which the cells were cultured was analyzed
quantitatively for hyaluronic acid content. The removed media were normalized for total
protein content before analysis. Using an ELISA assay, 44 medium samples (22
experimental, 22 control) were analyzed. The medium of tenocytes which had
experienced cyclical mechanical strain had a greater concentration of hyaluronic acid
(1528 ± 58 ng/mL (mean ± SEM)) compared with the medium of tenocytes that had not
been subject to strain (730 ± 27 ng/mL). This constitutes nearly a two fold increase in
hyaluronic acid content (p <.0001). (See Table 1).
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Table 1

Strained
Static

Hyaluronic Acid
ng/mL
1528 +/- 58
793 +/- 27

Assay
CD44 Receptor
O.D.
25525 +/- 2461
15454 +/- 1443

Glycosaminoglycans
µg/mL
10.2 +/- 0.6
15.3 +/- 3.0

p value

< .0001

0.024

0.103

Group

Comparisons between strained and static cells for hyaluronic acid, CD44, and
glycosaminoglycan content. Values are mean ± standard error of the mean.

CD44 receptor expression
Hyaluronic acid as a signaling molecule acts primarily through its receptor,
CD44. To assess whether there were changes in the population of the CD44 receptor, the
cell membranes of the tenocytes were analyzed for the presence of CD44. To allow for
the transcription and membrane translocation of the receptors, a delay of 24 hours
between the end of the mechanical strain regimen and collection was instituted. Using a
western blot analysis, 6 (3 experimental, 3 control) cellular homogenate samples from
independent cell lineages were analyzed for expression of CD44. (See figure 1).
Tenocytes under mechanical strain increased their concentration of CD44 by 62.5%, with
tenocytes exposed to strain having an optical density of 26 · 103 ± 2 · 103 compared with
15 · 103 ± 1 · 103 in controls (p<.05). (See table 1).
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Figure 1

Strain1 Strain2 Strain3 Static1 Static2 Static3
Inset of western blot for CD44. Lanes 1 through 3 represent the increased
signal in experimental cells exposed to cyclic strain compared to control lanes
4 through 6 which shows CD44 production in static cells.

Total glycosaminoglycan content
The total amount of glycosaminoglycan produced by tenocytes in both the
strained and static groups was measured to examine what effect mechanical strain had on
the production of these structural polysaccharides. Using a commercially available
colormetric dye-binding assay, 44 medium samples (22 experimental, 22 control) were
analyzed for content of glycosaminoglycans. No significant differences were detected in
glycosaminoglycan content between the media of tenocytes which had been cyclically
strained versus cells which were not, with strained cells producing 10.2 ± 0.6 µg/mL and
controls producing 15.3 ± 3.0 µg/mL (p = 0.103). (See Table 1).
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Discussion

Proper tendon healing after repair requires a balance between appropriate fibrous
connective tissue formation to provide tensile strength and the formation of excessive
scar tissue, fibrosis, which impedes the smooth gliding of structures and leads to
adhesions and impairment of function. Mechanical strain has been shown important in
this collagen production and the linear organization of collagen fibrils(54). Its role both
in animal models and clinical settings is widely accepted. The active rehabilitation
protocols used for hand surgery patients currently employed are designed to tread
between these two extremes: too little activity or strain can result in the formation of
adhesions, while excessive strain can result in rupture at the site of tenorraphy.
Understanding the effects of mechanical strain on tendon fibroblasts is important
in finding adjunct medical therapies which would mitigate fibrosis and adhesion
formation without weakening tendon repair. One such candidate is hyaluronic acid—a
high molecular weight polysaccharide found throughout the body that provides
lubrication in joints and the smooth gliding of tendons. More recently, research has
shown that in addition to its structural and lubricating role, hyaluronic acid as an
important signaling molecule for cell motility, adhesion, and proliferation.
Hyaluronic acid has been shown to be beneficial in preventing or decreasing
adhesions in animal models including chicken(142, 144, 149), rabbit(137, 143, 148, 152,
158), canine(136), horse(141), and primate.(150) Unfortunately, this success in animal
models has not translated into clinical applications.(42, 153, 154) This disappointing gap
suggests that a closer look at hyaluronic acid may be warranted.

29
Our study examined whether mechanical stress might directly influence
hyaluronic acid regulation. The model we chose was one in which rat tail tenocytes were
exposed to cyclic strain in vitro. One question that this raises is whether this is a valid
model for examining the effects on tendon fibroblasts.
Dissociated cells and tendon explants do appear to be good models for examining
the effects of mechanical strain on tenocytes. Dissociated tenocytes bond well to
fibronectin as demonstrated in biomaterial studies which examine adhesion strength.(165)
Tendon explants and dissociated fibroblasts grown in culture retain their ability to
respond to mechanical stress.(111, 161, 166-171) Moreover, the effects seen correlate
well with the effects of mechanical strain seen in vivo.(172-176)
Part of the difficulty in teasing apart the role of hyaluronic acid is that it seems to
behave differently based on its molecular weight, concentration, and the presence of other
growth factors. In fact, despite evidence that hyaluronic acid is a key molecule in tissue
healing, cell migration, and adhesion formation, we know little about how it is regulated.
Probably the most important regulator of hyaluronic acid is hyaluronic acid
synthase (HAS), particularly the second isoform, Has2(177, 178). In a study that
examined wound healing with cell lines that expressed sense and anti-sense Has2, the
increased cell migration and faster healing seen with sense Has2 was absent in cells
expressing anti-sense Has2. The anti-sense Has2 cells were also associated with an
increase in adhesive plaques. Exogenous hyaluronate was not able to overcome the
deficiency, suggesting that activation of Has2, more than the quantity of hyaluronic acid,
is the key determiner of how adhesions are formed and regulated by the hyaluronan
pathway.(179)
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This raises the question: if hyaluronic acid is beneficial to tendon healing, would
inhibiting the enzymes which degrade it (hyaluronidases) be beneficial as well? The
answer in tendons has not been explored. In intra-peritoneal adhesions however, where
some data suggest that hyaluronic acid is helpful in reducing the adhesion
formation(180), the effect has been examined(181, 182) and some researchers have seen
a benefit.(183)
In sum, it seems that hyaluronic acid has more than one role as a signaling
molecule. At a molecular level, hyaluronidase can suppress the rapid interactions that
occur early in cell adhesion formation. When a small amount of hyaluronic acid exists, it
can serve to facilitate cell-matrix adhesion, whereas excess hyaluronic acid strongly
inhibits cell adhesion.(184) Thus, it seems that hyaluronic acid may help to allow cells to
interact, move and bind together, while at the same time, larger amounts may help
prevent adhesion formation.
This study showed a significant increase in both hyaluronic acid and its receptor
(CD44) when tenocytes were exposed to cyclical mechanical strain in vitro. Our study is
the first to examine the effects of mechanical strain on the regulation of hyaluronic acid
in tendons. It is clear from our study that mechanical strain, which is an integral part of
the repair process, plays a role in the regulation of tendon fibroblast hyaluronic acid
production. How that translates into adhesion formation still needs to be explored,
however.
When we examined the total glycosaminoglycan content, it was not found to be
significantly altered by mechanical strain, though other investigators have shown
previously that many stimuli including in vitro culture alone can alter total and sulphated
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GAG content(111). The increase in hyaluronic acid, but not total glycosaminoglycan
content, may reflect the preferential effect of mechanical strain on the hyaluronan
pathway. Another possibility is that we did not observe any change in
glycosaminoglycan content in response to mechanical strain because of limitations of the
assay, which performed poorly even during calibration of standards. Additionally, the
assay we performed examined the presence of glycosaminoglycans in the supernatant.
The predominance of glycosaminoglycans may have been intimately associated with the
cell membranes and not readily present in the supernatant.
Hyaluronic acid is a promising target for mitigating adhesion formation.
Unfortunately, the clinical applications to date related to post-operative tendon repair
have been disappointing(153, 154). In addition to the complexities of its regulation and
mechanisms of action, use of hyaluronic acid has been challenged by its rapid catabolism
and dilution in the body.
Newer, derivatized formulations of HA show longer persistence and less friction
in tendons after repair(185) and have been used for a variety of purposes(186) from
coating metallic artificial joints(187) to forming biologically compatible hydrogels.(188)
Other researchers have created cross-linked hyaluronic acid films which contain DNA
encoding hyaluronan synthase 2 (HAS2). The goal of these biofilms is to provide a
physical barrier while at the same time delivering hyaluronan and upregulating HAS.
The films are subject to the same catabolism by hyaluronidases as native hyaluronic acid,
and as such subject to breakdown, but cross-linked hyaluronic acid-collagen sheets which
are resistant to hyaluronidase over several weeks have been developed.(189) Hopefully,
these promising discoveries will translate into viable clinical applications.
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The future role of hyaluronic acid as an adjunct medical therapy to prevent the
formation of adhesions after tendon surgery is unclear. The current challenges in
understanding how hyaluronic acid fits into the larger process of wound healing are
interesting avenues of research, however, and as the details of its regulation and
mechanisms of action are revealed, perhaps a clearer path to preventing tendon adhesions
will be as well.

33

References

1.
2.
3.
4.
5.

6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.

Manske, P.R., History of flexor tendon repair. Hand Clin, 2005. 21(2): 123-7.
Strickland, J.W., Flexor tendon injuries. Part 1. Anatomy, physiology,
biomechanics, healing, and adhesion formation around a repaired tendon. Orthop
Rev, 1986. 15(10): 632-45.
Potenza, A.D., Tendon healing within the flexor digital sheath in the dog. J Bone
Joint Surg Am, 1962. 44-A: 49-64.
Gelberman, R.H. and P.R. Manske, Factors influencing flexor tendon adhesions.
Hand Clin, 1985. 1(1): 35-42.
Hagberg, L., O. Wik, and B. Gerdin, Determination of biomechanical
characteristics of restrictive adhesions and of functional impairment after flexor
tendon surgery: a methodological study of rabbits. J Biomech, 1991. 24(10): 93542.
Masuda, K., et al., Biochemical analysis of collagen in adhesive tissues formed
after digital flexor tendon injuries. J Orthop Sci, 2002. 7(6): 665-71.
Ragoowansi, R., et al., Differences in morphology, cytoskeletal architecture and
protease production between zone II tendon and synovial fibroblasts in vitro. J
Hand Surg [Br], 2003. 28(5): 465-70.
Belmahi, A., N.E. Gharib, and S. El Mazouz, [The protected tendinous graft in
zone 2 or fibroblast trap]. Chir Main, 2004. 23(3): 142-8.
Frykman, E., S. Jacobsson, and B. Widenfalk, Fibrin sealant in prevention of
flexor tendon adhesions: an experimental study in the rabbit. J Hand Surg [Am],
1993. 18(1): 68-75.
Tan, V., et al., Interosseous-lumbrical adhesions of the hand: contribution of
magnetic resonance imaging to diagnosis and treatment planning. J Hand Surg
[Am], 2002. 27(4): 639-43.
Langley, P.L., Iontophoresis to aid in releasing tendon adhesions. Suggestion
from the field. Phys Ther, 1984. 64(9): 1395.
Robotti, E., et al., The effect of pulsed electromagnetic fields on flexor tendon
healing in chickens. J Hand Surg [Br], 1999. 24(1): 56-8.
Greenough, C.G., The effect of pulsed electromagnetic fields on flexor tendon
healing in the rabbit. J Hand Surg [Br], 1996. 21(6): 808-12.
Healy, C., et al., Postoperative stiffness and adhesion formation around repaired
and immobilized Achilles tenotomies are prevented using a model of heat shock
protein induction. J Surg Res, 2004. 120(2): 225-9.
Mulhall, K.J., et al., Thermal preconditioning prevents peritendinous adhesions
and inflammation. Clin Orthop Relat Res, 2002(405): 258-66.
Szabo, R.M. and E. Younger, Effects of indomethacin on adhesion formation after
repair of zone II tendon lacerations in the rabbit. J Hand Surg [Am], 1990. 15(3):
480-3.

34
17.
18.
19.
20.
21.
22.
23.
24.
25.

26.
27.
28.
29.
30.
31.
32.
33.

Carlstedt, C.A., Mechanical and chemical factors in tendon healing. Effects of
indomethacin and surgery in the rabbit. Acta Orthop Scand Suppl, 1987. 224: 175.
Carlstedt, C.A., K. Madsen, and T. Wredmark, The influence of indomethacin on
biomechanical and biochemical properties of the plantaris longus tendon in the
rabbit. Arch Orthop Trauma Surg, 1987. 106(3): 157-60.
Carlstedt, C.A., K. Madsen, and T. Wredmark, The influence of indomethacin on
tendon healing. A biomechanical and biochemical study. Arch Orthop Trauma
Surg, 1986. 105(6): 332-6.
Kulick, M.I., S. Smith, and K. Hadler, Oral ibuprofen: evaluation of its effect on
peritendinous adhesions and the breaking strength of a tenorrhaphy. J Hand Surg
[Am], 1986. 11(1): 110-20.
Kulick, M.I., et al., Injectable ibuprofen: preliminary evaluation of its ability to
decrease peritendinous adhesions. Ann Plast Surg, 1984. 13(6): 459-67.
Sullo, A., et al., The effects of prolonged peritendinous administration of PGE1 to
the rat Achilles tendon: a possible animal model of chronic Achilles tendinopathy.
J Orthop Sci, 2001. 6(4): 349-57.
Ketchum, L.D., Effects of triamcinolone on tendon healing and function. A
laboratory study. Plast Reconstr Surg, 1971. 47(5): 471-82.
Kapetanos, G., The effect of the local corticosteroids on the healing and
biomechanical properties of the partially injured tendon. Clin Orthop Relat Res,
1982(163): 170-9.
Douglas, L.G., S.H. Jackson, and W.K. Lindsay, The effects of dexamethasone,
norethandrolone, promethazine and a tension-relieving procedure on collagen
synthesis in healing flexor tendons as estimated by tritiated proline uptake studies.
Can J Surg, 1967. 10(1): 36-46.
Walker, F.G., S.H. Bensley, and W.K. Lindsay, The effects of an antihistamine
(promethazine) on the reaction of tendons to trauma (a histological study). Acta
Chir Plast, 1965. 7(3): 171-86.
Lane, J.M., J. Black, and F.W. Bora, Jr., Gliding function following flexor-tendon
injury. A biomechanical study of rat tendon function. J Bone Joint Surg Am,
1976. 58(7): 985-90.
Akali, A., et al., Decrease in adhesion formation by a single application of 5fluorouracil after flexor tendon injury. Plast Reconstr Surg, 1999. 103(1): 151-8.
Khan, U., et al., Modulation of the formation of adhesions during the healing of
injured tendons. J Bone Joint Surg Br, 2000. 82(7): 1054-8.
Moran, S.L., et al., Effects of 5-fluorouracil on flexor tendon repair. J Hand Surg
[Am], 2000. 25(2): 242-51.
Cerovac, S., et al., Early breaking strength of repaired flexor tendon treated with
5-fluorouracil. J Hand Surg [Br], 2001. 26(3): 220-3.
Ragoowansi, R., et al., Reduction in matrix metalloproteinase production by
tendon and synovial fibroblasts after a single exposure to 5-fluorouracil. Br J
Plast Surg, 2001. 54(4): 283-7.
Komurcu, M., et al., Reduction of restrictive adhesions by local aprotinin
application and primary sheath repair in surgically traumatized flexor tendons of
the rabbit. J Hand Surg [Am], 1997. 22(5): 826-32.

35
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.

Nyska, M., et al., Topically applied halofuginone, an inhibitor of collagen type I
transcription, reduces peritendinous fibrous adhesions following surgery. Connect
Tissue Res, 1996. 34(2): 97-103.
Speer, D.P., S. Feldman, and M. Chvapil, The control of peritendinous adhesions
using topical beta-aminopropionitrile base. J Surg Res, 1985. 38(3): 252-7.
Porat, S., et al., Increased collagenolytic activity in severed and sutured tendons
following topical application of exogenous collagen in chickens. J Orthop Res,
1985. 3(1): 43-8.
Porat, S., M. Rousso, and S. Shoshan, Improvement of gliding function of flexor
tendons by topically applied enriched collagen solution. J Bone Joint Surg Br,
1980. 62-B(2): 208-13.
Nyska, M., et al., Decreased adhesion formation in flexor tendons by topical
application of enriched collagen solution--a histological study. Arch Orthop
Trauma Surg, 1987. 106(3): 192-4.
Hanff, G. and L. Hagberg, Prevention of restrictive adhesions with expanded
polytetrafluoroethylene diffusible membrane following flexor tendon repair: an
experimental study in rabbits. J Hand Surg [Am], 1998. 23(4): 658-64.
Kobayashi, M., J. Toguchida, and M. Oka, Development of polyvinyl alcoholhydrogel (PVA-H) shields with a high water content for tendon injury repair. J
Hand Surg [Br], 2001. 26(5): 436-40.
Gudemez, E., et al., Chondroitin sulfate-coated polyhydroxyethyl methacrylate
membrane prevents adhesion in full-thickness tendon tears of rabbits. J Hand
Surg [Am], 2002. 27(2): 293-306.
Strickland, J.W., Development of flexor tendon surgery: twenty-five years of
progress. J Hand Surg [Am], 2000. 25(2): 214-35.
Siddiqi, N.A., et al., Effects of hydroxyapatite and alumina sheaths on
postoperative peritendinous adhesions in chickens. J Appl Biomater, 1995. 6(1):
43-53.
Smith, D.J., Jr., et al., Use of glutaraldehyde stabilized mammalian pericardium in
hand surgery. Ann Chir Main, 1988. 7(1): 54-7.
Stark, H.H., et al., The use of paratenon, polyethylene film, or silastic sheeting to
prevent restricting adhesions to tendons in the hand. J Bone Joint Surg Am, 1977.
59(7): 908-13.
Golash, A., et al., Efficacy of ADCON-T/N after primary flexor tendon repair in
Zone II: a controlled clinical trial. J Hand Surg [Br], 2003. 28(2): 113-5.
Mentzel, M., et al., The effectiveness of ADCON-T/N, a new anti-adhesion
barrier gel, in fresh divisions of the flexor tendons in Zone II. J Hand Surg [Br],
2000. 25(6): 590-2.
Silfverskiold, K.L. and E.J. May, Flexor tendon repair in zone II with a new
suture technique and an early mobilization program combining passive and active
flexion. J Hand Surg [Am], 1994. 19(1): 53-60.
Peck, F.H., et al., A comparative study of two methods of controlled mobilization
of flexor tendon repairs in zone 2. J Hand Surg [Br], 1998. 23(1): 41-5.
Harris, S.B., et al., The aetiology of acute rupture of flexor tendon repairs in zones
1 and 2 of the fingers during early mobilization. J Hand Surg [Br], 1999. 24(3):
275-80.

36
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.

Lister, G.D., et al., Primary flexor tendon repair followed by immediate controlled
mobilization. J Hand Surg [Am], 1977. 2(6): 441-51.
Becker, H., F. Orak, and E. Duponselle, Early active motion following a beveled
technique of flexor tendon repair: report on fifty cases. J Hand Surg [Am], 1979.
4(5): 454-60.
Strickland, J.W., Results of flexor tendon surgery in zone II. Hand Clin, 1985.
1(1): 167-79.
Strickland, J.W. and S.V. Glogovac, Digital function following flexor tendon
repair in Zone II: A comparison of immobilization and controlled passive motion
techniques. J Hand Surg [Am], 1980. 5(6): 537-43.
Gault, D.T., Reduction of grip strength, finger flexion pressure, finger pinch
pressure and key pinch following flexor tendon repair. J Hand Surg [Br], 1987.
12(2): 182-4.
Singer, M. and S. Maloon, Flexor tendon injuries: the results of primary repair. J
Hand Surg [Br], 1988. 13(3): 269-72.
Chow, J.A., et al., Controlled motion rehabilitation after flexor tendon repair and
grafting. A multi-centre study. J Bone Joint Surg Br, 1988. 70(4): 591-5.
Small, J.O., M.D. Brennen, and J. Colville, Early active mobilisation following
flexor tendon repair in zone 2. J Hand Surg [Br], 1989. 14(4): 383-91.
Cullen, K.W., et al., Flexor tendon repair in zone 2 followed by controlled active
mobilisation. J Hand Surg [Br], 1989. 14(4): 392-5.
Savage, R. and G. Risitano, Flexor tendon repair using a "six strand" method of
repair and early active mobilisation. J Hand Surg [Br], 1989. 14(4): 396-9.
May, E.J., K.L. Silfverskiold, and C.J. Sollerman, Controlled mobilization after
flexor tendon repair in zone II: a prospective comparison of three methods. J
Hand Surg [Am], 1992. 17(5): 942-52.
Bainbridge, L.C., et al., A comparison of post-operative mobilization of flexor
tendon repairs with "passive flexion-active extension" and "controlled active
motion" techniques. J Hand Surg [Br], 1994. 19(4): 517-21.
Elliot, D., et al., The rupture rate of acute flexor tendon repairs mobilized by the
controlled active motion regimen. J Hand Surg [Br], 1994. 19(5): 607-12.
Baktir, A., et al., Flexor tendon repair in zone 2 followed by early active
mobilization. J Hand Surg [Br], 1996. 21(5): 624-8.
Kitsis, C.K., et al., Controlled active motion following primary flexor tendon
repair: a prospective study over 9 years. J Hand Surg [Br], 1998. 23(3): 344-9.
Aoki, M., et al., Biomechanical and histologic characteristics of canine flexor
tendon repair using early postoperative mobilization. J Hand Surg [Am], 1997.
22(1): 107-14.
Pruitt, D.L., et al., Cyclic stress testing after in vivo healing of canine flexor
tendon lacerations. J Hand Surg [Am], 1996. 21(6): 974-7.
Wada, A., et al., Comparison of postoperative early active mobilization and
immobilization in vivo utilising a four-strand flexor tendon repair. J Hand Surg
[Br], 2001. 26(4): 301-6.
Feehan, L.M. and J.G. Beauchene, Early tensile properties of healing chicken
flexor tendons: early controlled passive motion versus postoperative
immobilization. J Hand Surg [Am], 1990. 15(1): 63-8.

37
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.

Gelberman, R.H., et al., The excursion and deformation of repaired flexor tendons
treated with protected early motion. J Hand Surg [Am], 1986. 11(1): 106-10.
Gelberman, R.H., et al., Effects of early intermittent passive mobilization on
healing canine flexor tendons. J Hand Surg [Am], 1982. 7(2): 170-5.
Gelberman, R.H., et al., Flexor tendon repair. J Orthop Res, 1986. 4(1): 119-28.
Takai, S., et al., The effects of frequency and duration of controlled passive
mobilization on tendon healing. J Orthop Res, 1991. 9(5): 705-13.
Gelberman, R.H., et al., Influences of the protected passive mobilization interval
on flexor tendon healing. A prospective randomized clinical study. Clin Orthop
Relat Res, 1991(264): 189-96.
Evans, R.B., Clinical application of controlled stress to the healing extensor
tendon: a review of 112 cases. Phys Ther, 1989. 69(12): 1041-9.
Evans, R.B. and D.E. Thompson, The application of force to the healing tendon. J
Hand Ther, 1993. 6(4): 266-84.
Chao, R.P., et al., Early passive mobilization after digital nerve repair and grafting
in a fresh cadaver. Plast Reconstr Surg, 2001. 108(2): 386-91.
Woo, S.L., et al., The importance of controlled passive mobilization on flexor
tendon healing. A biomechanical study. Acta Orthop Scand, 1981. 52(6): 615-22.
Bunker, T.D., B. Potter, and N.J. Barton, Continuous passive motion following
flexor tendon repair. J Hand Surg [Br], 1989. 14(4): 406-11.
Tran, H.N., et al., In vitro cyclic tensile testing of combined peripheral and core
flexor tenorrhaphy suture techniques. J Hand Surg [Am], 2002. 27(3): 518-24.
Zhao, C., et al., Remodeling of the gliding surface after flexor tendon repair in a
canine model in vivo. J Orthop Res, 2002. 20(4): 857-62.
Momose, T., et al., Surface modification of extrasynovial tendon by chemically
modified hyaluronic acid coating. J Biomed Mater Res, 2002. 59(2): 219-24.
Matthews, P. and H. Richards, Factors in the adherence of flexor tendon after
repair: an experimental study in the rabbit. J Bone Joint Surg Br, 1976. 58(2):
230-6.
Banes, A.J., et al., Mechanical load stimulates expression of novel genes in vivo
and in vitro in avian flexor tendon cells. Osteoarthritis Cartilage, 1999. 7(1): 14153.
Orhan, Z., et al., The effect of extracorporeal shock waves on a rat model of
injury to tendo Achillis. A histological and biomechanical study. J Bone Joint
Surg Br, 2004. 86(4): 613-8.
Tanaka, H., et al., Effect of cyclic tension on lacerated flexor tendons in vitro. J
Hand Surg [Am], 1995. 20(3): 467-73.
Mass, D.P., et al., Effects of constant mechanical tension on the healing of rabbit
flexor tendons. Clin Orthop Relat Res, 1993(296): 301-6.
Wray, R.C., Jr., et al., Effect of continuous load on the mechanical properties of
tendon adhesions. Hand, 1981. 13(1): 92-6.
Kubota, H., et al., Effect of motion and tension on injured flexor tendons in
chickens. J Hand Surg [Am], 1996. 21(3): 456-63.
Silva, M.J., et al., Effects of increased in vivo excursion on digital range of
motion and tendon strength following flexor tendon repair. J Orthop Res, 1999.
17(5): 777-83.

38
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.

Fong, K.D., et al., Microarray analysis of mechanical shear effects on flexor
tendon cells. Plast Reconstr Surg, 2005. 116(5): 1393-404; discussion 1405-6.
Abrahamsson, S.O., G. Lundborg, and L.S. Lohmander, Tendon healing in vivo.
An experimental model. Scand J Plast Reconstr Surg Hand Surg, 1989. 23(3):
199-205.
Abrahamsson, S.O., G. Lundborg, and L.S. Lohmander, Recombinant human
insulin-like growth factor-I stimulates in vitro matrix synthesis and cell
proliferation in rabbit flexor tendon. J Orthop Res, 1991. 9(4): 495-502.
Abrahamsson, S.O., G. Lundborg, and L.S. Lohmander, Long-term explant
culture of rabbit flexor tendon: effects of recombinant human insulin-like growth
factor-I and serum on matrix metabolism. J Orthop Res, 1991. 9(4): 503-15.
Zhang, A.Y., et al., Inhibition of TGF-beta-induced collagen production in rabbit
flexor tendons. J Hand Surg [Am], 2004. 29(2): 230-5.
Klein, M.B., et al., Flexor tendon healing in vitro: effects of TGF-beta on tendon
cell collagen production. J Hand Surg [Am], 2002. 27(4): 615-20.
Chang, J., et al., Studies in flexor tendon wound healing: neutralizing antibody to
TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg, 2000.
105(1): 148-55.
Chang, J., et al., Gene expression of transforming growth factor beta-1 in rabbit
zone II flexor tendon wound healing: evidence for dual mechanisms of repair.
Plast Reconstr Surg, 1997. 100(4): 937-44.
Tsubone, T., et al., Expression of growth factors in canine flexor tendon after
laceration in vivo. Ann Plast Surg, 2004. 53(4): 393-7.
Ngo, M., et al., Differential expression of transforming growth factor-beta
receptors in a rabbit zone II flexor tendon wound healing model. Plast Reconstr
Surg, 2001. 108(5): 1260-7.
Gelberman, R.H., et al., Angiogenesis in healing autogenous flexor-tendon grafts.
J Bone Joint Surg Am, 1992. 74(8): 1207-16.
Ditsios, K., et al., Neovascularization of the flexor digitorum profundus tendon
after avulsion injury: an in vivo canine study. J Hand Surg [Am], 2003. 28(2):
231-6.
Gelberman, R.H., et al., The effects of mobilization on the vascularization of
healing flexor tendons in dogs. Clin Orthop Relat Res, 1980(153): 283-9.
Darmani, H., J.C. Crossan, and A. Curtis, Single dose of inducible nitric oxide
synthase inhibitor induces prolonged inflammatory cell accumulation and fibrosis
around injured tendon and synovium. Mediators Inflamm, 2004. 13(3): 157-64.
Klein, M.B., et al., Flexor tendon wound healing in vitro: the effect of lactate on
tendon cell proliferation and collagen production. J Hand Surg [Am], 2001. 26(5):
847-54.
Mehta, V., et al., Characterization of adenovirus-mediated gene transfer in rabbit
flexor tendons. J Hand Surg [Am], 2005. 30(1): 136-41.
Shimomura, T., et al., Antisense oligonucleotides reduce synthesis of procollagen
alpha1 (V) chain in human patellar tendon fibroblasts: potential application in
healing ligaments and tendons. Connect Tissue Res, 2003. 44(3-4): 167-72.
Dykyj, D. and K.T. Jules, The clinical anatomy of tendons. J Am Podiatr Med
Assoc, 1991. 81(7): 358-65.

39
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.

Vailas, A.C., et al., Physical activity and hypophysectomy on the aerobic capacity
of ligaments and tendons. J Appl Physiol, 1978. 44(4): 542-6.
Williams, J.G., Achilles tendon lesions in sport. Sports Med, 1986. 3(2): 114-35.
Slack, C., et al., Changes in the morphology and synthetic activity of cultured rat
tail tendon. Cell Tissue Res, 1986. 245(2): 359-68.
Kastelic, J., A. Galeski, and E. Baer, The multicomposite structure of tendon.
Connect Tissue Res, 1978. 6(1): 11-23.
Wilson, T.W., M.P. Zafuta, and M. Zobitz, A biomechanical analysis of matched
bone-patellar tendon-bone and double-looped semitendinosus and gracilis tendon
grafts. Am J Sports Med, 1999. 27(2): 202-7.
Tammi, M.I., A.J. Day, and E.A. Turley, Hyaluronan and homeostasis: a
balancing act. J Biol Chem, 2002. 277(7): 4581-4.
Day, A.J. and G.D. Prestwich, Hyaluronan-binding proteins: tying up the giant. J
Biol Chem, 2002. 277(7): 4585-8.
Olutoye, O.O., et al., Hyaluronic acid inhibits fetal platelet function: implications
in scarless healing. J Pediatr Surg, 1997. 32(7): 1037-40.
Shepard, S., H. Becker, and J.X. Hartmann, Using hyaluronic acid to create a
fetal-like environment in vitro. Ann Plast Surg, 1996. 36(1): 65-9.
Alaish, S.M., et al., Biology of fetal wound healing: hyaluronate receptor
expression in fetal fibroblasts. J Pediatr Surg, 1994. 29(8): 1040-3.
Dillon, P.W., et al., The extracellular matrix of the fetal wound: hyaluronic acid
controls lymphocyte adhesion. J Surg Res, 1994. 57(1): 170-3.
al-Qattan, M.M., et al., Fetal tendon healing: development of an experimental
model. Plast Reconstr Surg, 1993. 92(6): 1155-60; discussion 1161.
Meinert, M., et al., Proteoglycans and hyaluronan in human fetal membranes. Am
J Obstet Gynecol, 2001. 184(4): 679-85.
Luo, J., Z. Yang, and X. Li, [Effect of human acellular amnion membrane on
tendon adhesion in rat]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2004.
18(5): 431-4.
Demirkan, F., et al., The use of amniotic membrane in flexor tendon repair: an
experimental model. Arch Orthop Trauma Surg, 2002. 122(7): 396-9.
Ozgenel, G.Y., The effects of a combination of hyaluronic and amniotic
membrane on the formation of peritendinous adhesions after flexor tendon
surgery in chickens. J Bone Joint Surg Br, 2004. 86(2): 301-7.
Ozgenel, G.Y., B. Samli, and M. Ozcan, Effects of human amniotic fluid on
peritendinous adhesion formation and tendon healing after flexor tendon surgery
in rabbits. J Hand Surg [Am], 2001. 26(2): 332-9.
Obara, T., et al., Increased friction of animal joints by experimental degeneration
and recovery by addition of hyaluronic acid. Clin Biomech (Bristol, Avon), 1997.
12(4): 246-252.
Mabuchi, K., et al., The effect of additive hyaluronic acid on animal joints with
experimentally reduced lubricating ability. J Biomed Mater Res, 1994. 28(8): 86570.
Noble, P.W., Hyaluronan and its catabolic products in tissue injury and repair.
Matrix Biol, 2002. 21(1): 25-9.

40
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.

143.
144.
145.
146.

Mabuchi, K., et al., Molecular weight independence of the effect of additive
hyaluronic acid on the lubricating characteristics in synovial joints with
experimental deterioration. Clin Biomech (Bristol, Avon), 1999. 14(5): 352-6.
Collis, L., et al., Rapid hyaluronan uptake is associated with enhanced motility:
implications for an intracellular mode of action. FEBS Lett, 1998. 440(3): 444-9.
Evanko, S.P. and T.N. Wight, Intracellular localization of hyaluronan in
proliferating cells. J Histochem Cytochem, 1999. 47(10): 1331-42.
Aruffo, A., et al., CD44 is the principal cell surface receptor for hyaluronate. Cell,
1990. 61(7): 1303-13.
Goldstein, L.A., et al., A human lymphocyte homing receptor, the hermes antigen,
is related to cartilage proteoglycan core and link proteins. Cell, 1989. 56(6): 106372.
Pure, E. and C.A. Cuff, A crucial role for CD44 in inflammation. Trends Mol
Med, 2001. 7(5): 213-21.
Lesley, J. and R. Hyman, CD44 structure and function. Front Biosci, 1998. 3:
d616-30.
Amiel, D., et al., Hyaluronan in flexor tendon repair. J Hand Surg [Am], 1989.
14(5): 837-43.
Thomas, S.C., L.C. Jones, and D.S. Hungerford, Hyaluronic acid and its effect on
postoperative adhesions in the rabbit flexor tendon. A preliminary look. Clin
Orthop Relat Res, 1986(206): 281-9.
Akasaka, T., et al., Hyaluronic acid diminishes the resistance to excursion after
flexor tendon repair: an in vitro biomechanical study. J Biomech, 2005. 38(3):
503-7.
Nishida, J., et al., Effect of hyaluronic acid on the excursion resistance of tendon
grafts. A biomechanical study in a canine model in vitro. J Bone Joint Surg Br,
2004. 86(6): 918-24.
Halici, M., et al., Sodium hyaluronate regulating angiogenesis during Achilles
tendon healing. Knee Surg Sports Traumatol Arthrosc, 2004. 12(6): 562-7.
Gaughan, E.M., et al., Effects of sodium hyaluronate on tendon healing and
adhesion formation in horses. Am J Vet Res, 1991. 52(5): 764-73.
Yuzawa, K., [Experimental studies on the healing and restoration of gliding
function of the injured digital flexor tendon. Part 9: The use of drugs to prevent
adhesion formation of the injured tendon]. Nippon Seikeigeka Gakkai Zasshi,
1985. 59(12): 1107-18.
Xu, J., Y. Gu, and H. Wang, [Experimental study of sodium hyaluronate products
on prevention of tendon adhesion]. Zhonghua Wai Ke Za Zhi, 1995. 33(9): 52931.
Chen, Z. and J. Gu, [Experimental research on using macromolecule sodium
hyaluronate to prevent flexior tendon adhesion]. Zhonghua Wai Ke Za Zhi, 1995.
33(9): 526-8.
Tuncay, I., et al., Effects of hyaluronic acid on postoperative adhesion of tendo
calcaneus surgery: an experimental study in rats. J Foot Ankle Surg, 2002. 41(2):
104-8.
Meyers, S.A., et al., Effect of hyaluronic acid/chondroitin sulfate on healing of
full-thickness tendon lacerations in rabbits. J Orthop Res, 1989. 7(5): 683-9.

41
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.

Green, S., et al., The inhibition of flexor tendon adhesions. Bull Hosp Jt Dis
Orthop Inst, 1986. 46(1): 16-21.
Menderes, A., et al., Prevention of peritendinous adhesions following flexor
tendon injury with seprafilm. Ann Plast Surg, 2004. 53(6): 560-4.
Karakurum, G., et al., Seprafilm interposition for preventing adhesion formation
after tenolysis. An experimental study on the chicken flexor tendons. J Surg Res,
2003. 113(2): 195-200.
St Onge, R., et al., A preliminary assessment of Na-hyaluronate injection into "no
man's land" for primary flexor tendon repair. Clin Orthop Relat Res, 1980(146):
269-75.
Moro-oka, T., et al., Mixture of hyaluronic acid and phospholipid prevents
adhesion formation on the injured flexor tendon in rabbits. J Orthop Res, 2000.
18(5): 835-40.
Wiig, M., S.O. Abrahamsson, and G. Lundborg, Effects of hyaluronan on cell
proliferation and collagen synthesis: a study of rabbit flexor tendons in vitro. J
Hand Surg [Am], 1996. 21(4): 599-604.
Hagberg, L., Exogenous hyaluronate as an adjunct in the prevention of adhesions
after flexor tendon surgery: a controlled clinical trial. J Hand Surg [Am], 1992.
17(1): 132-6.
Taras, J.S. and M.J. Lamb, Treatment of flexor tendon injuries: surgeons'
perspective. J Hand Ther, 1999. 12(2): 141-8.
Hagberg, L., A. Tengblad, and B. Gerdin, Elimination of exogenously injected
sodium-hyaluronate from rabbit flexor tendon sheaths. J Orthop Res, 1991. 9(6):
792-7.
Hagberg, L. and B. Gerdin, Sodium hyaluronate as an adjunct in adhesion
prevention after flexor tendon surgery in rabbits. J Hand Surg [Am], 1992. 17(5):
935-41.
Isik, S., et al., Prevention of restrictive adhesions in primary tendon repair by HAmembrane: experimental research in chickens. Br J Plast Surg, 1999. 52(5): 3739.
Weiss, C., et al., The role of Na-hylan in reducing postsurgical tendon adhesions.
Bull Hosp Jt Dis Orthop Inst, 1986. 46(1): 9-15.
Weiss, C., et al., The role of Na-hylan in reducing postsurgical tendon adhesions:
Part 2. Bull Hosp Jt Dis Orthop Inst, 1987. 47(1): 31-9.
Wang, S.J., et al., [The clinical study of adhesion prevention of sodium
hyaluronate in flexor tendon surgery]. Zhongguo Xiu Fu Chong Jian Wai Ke Za
Zhi, 2002. 16(1): 28-30.
Banes, A.J., et al., PDGF-BB, IGF-I and mechanical load stimulate DNA
synthesis in avian tendon fibroblasts in vitro. J Biomech, 1995. 28(12): 1505-13.
Dowthwaite, G.P., et al., The effect of mechanical strain on hyaluronan
metabolism in embryonic fibrocartilage cells. Matrix Biol, 1999. 18(6): 523-32.
Arnoczky, S.P., et al., Activation of stress-activated protein kinases (SAPK) in
tendon cells following cyclic strain: the effects of strain frequency, strain
magnitude, and cytosolic calcium. J Orthop Res, 2002. 20(5): 947-52.

42
164.
165.
166.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.

Zeichen, J., M. van Griensven, and U. Bosch, The proliferative response of
isolated human tendon fibroblasts to cyclic biaxial mechanical strain. Am J Sports
Med, 2000. 28(6): 888-92.
Qin, T.W., et al., Adhesion strength of human tenocytes to extracellular matrix
component-modified poly(DL-lactide-co-glycolide) substrates. Biomaterials,
2005. 26(33): 6635-42.
Koob, T.J., Biomimetic approaches to tendon repair. Comp Biochem Physiol A
Mol Integr Physiol, 2002. 133(4): 1171-92.
Yamamoto, E., et al., Effects of static stress on the mechanical properties of
cultured collagen fascicles from the rabbit patellar tendon. J Biomech Eng, 2002.
124(1): 85-93.
Ralphs, J.R., A.D. Waggett, and M. Benjamin, Actin stress fibres and cell-cell
adhesion molecules in tendons: organisation in vivo and response to mechanical
loading of tendon cells in vitro. Matrix Biol, 2002. 21(1): 67-74.
Hannafin, J.A., et al., Effect of stress deprivation and cyclic tensile loading on the
material and morphologic properties of canine flexor digitorum profundus tendon:
an in vitro study. J Orthop Res, 1995. 13(6): 907-14.
Koob, T.J., et al., Compression loading in vitro regulates proteoglycan synthesis
by tendon fibrocartilage. Arch Biochem Biophys, 1992. 298(1): 303-12.
Slack, C., M.H. Flint, and B.M. Thompson, The effect of tensional load on
isolated embryonic chick tendons in organ culture. Connect Tissue Res, 1984.
12(3-4): 229-47.
Gillard, G.C., et al., The influence of mechanical forces on the
glycosaminoglycan content of the rabbit flexor digitorum profundus tendon.
Connect Tissue Res, 1979. 7(1): 37-46.
Woo, S.L., et al., The effects of exercise on the biomechanical and biochemical
properties of swine digital flexor tendons. J Biomech Eng, 1981. 103(1): 51-6.
Malaviya, P., et al., An in vivo model for load-modulated remodeling in the rabbit
flexor tendon. J Orthop Res, 2000. 18(1): 116-25.
Buchanan, C.I. and R.L. Marsh, Effects of exercise on the biomechanical,
biochemical and structural properties of tendons. Comp Biochem Physiol A Mol
Integr Physiol, 2002. 133(4): 1101-7.
Packer, D.L., et al., An in vitro model of fibroblast activity and adhesion
formation during flexor tendon healing. J Hand Surg [Am], 1994. 19(5): 769-76.
Spicer, A.P. and J.A. McDonald, Characterization and molecular evolution of a
vertebrate hyaluronan synthase gene family. J Biol Chem, 1998. 273(4): 1923-32.
Weigel, P.H., V.C. Hascall, and M. Tammi, Hyaluronan synthases. J Biol Chem,
1997. 272(22): 13997-4000.
Rilla, K., et al., Changed lamellipodial extension, adhesion plaques and migration
in epidermal keratinocytes containing constitutively expressed sense and antisense
hyaluronan synthase 2 (Has2) genes. J Cell Sci, 2002. 115(Pt 18): 3633-43.
Falk, K., et al., Prevention of adhesions by surfactants and cellulose derivatives in
mice. Eur J Surg, 2001. 167(2): 136-41.
Khitrina, G.V., [The effect of hyaluronidase on adhesive processes in the pleural
cavity under experimental conditions]. Biull Eksp Biol Med, 1968. 65(4): 115-7.

43
182.
183.
184.
185.
186.
187.
188.

189.

Stoehr, B.J., J.E. Gutierrez, and A.S. Close, Effect of intraperitoneal
hyaluronidase on the reformation of intestinal adhesions. Am J Surg, 1966.
111(6): 881-3.
Adamian, L.V., O.A. Mynbaev, and V.M. Strugatskii, [An experimental
validation of hyaluronidase electrophoresis for the prevention of postoperative
adhesions]. Vopr Kurortol Fizioter Lech Fiz Kult, 1995(3): 18-20.
Zimmerman, E., B. Geiger, and L. Addadi, Initial stages of cell-matrix adhesion
can be mediated and modulated by cell-surface hyaluronan. Biophys J, 2002.
82(4): 1848-57.
Yang, C., et al., Tendon surface modification by chemically modified HA coating
after flexor digitorum profundus tendon repair. J Biomed Mater Res B Appl
Biomater, 2004. 68(1): 15-20.
Kelly, M.A., R.W. Moskowitz, and J.R. Lieberman, Hyaluronan therapy: looking
toward the future. Am J Orthop, 2004. 33(2 Suppl): 23-8.
Pitt, W.G., et al., Attachment of hyaluronan to metallic surfaces. J Biomed Mater
Res A, 2004. 68(1): 95-106.
Bulpitt, P. and D. Aeschlimann, New strategy for chemical modification of
hyaluronic acid: preparation of functionalized derivatives and their use in the
formation of novel biocompatible hydrogels. J Biomed Mater Res, 1999. 47(2):
152-69.
Tsai, S.W., et al., Preparation and evaluation of a hyaluronate-collagen film for
preventing post-surgical adhesion. J Int Med Res, 2005. 33(1): 68-76.

